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Abstract
Background: Population attributable risks (PARs) are useful tool to estimate the burden of risk factors in cancer
incidence. Few studies estimated the PARs of oral cavity cancer to tobacco smoking alone, alcohol drinking alone
and their joint consumption but none performed analysis stratified by subsite, gender or age. Among the
suspected risk factors of oral cavity cancer, only PAR to a family history of head and neck cancer was reported in
two studies. The purpose of this study was to estimate in France the PARs of oral cavity cancer to several
recognized and suspected risk factors, overall and by subsite, gender and age.
Methods: We analysed data from 689 oral cavity cancer cases and 3481 controls included in a population-based
case–control study, the ICARE study. Unconditional logistic regression models were used to estimate odds ratios
(ORs), PARs and 95 % confidence intervals (95 % CI).
Results: The PARs were 0.3 % (95 % CI −3.9 %; +3.9 %) for alcohol alone, 12.7 % (6.9 %–18.0 %) for tobacco alone
and 69.9 % (64.4 %–74.7 %) for their joint consumption. PAR to combined alcohol and tobacco consumption was
74 % (66.5 %–79.9 %) in men and 45.4 % (32.7 %–55.6 %) in women. Among suspected risk factors, body mass
index 2 years before the interview <25 kg.m−2, never tea drinking and family history of head and neck cancer
explained 35.3 % (25.7 %–43.6 %), 30.3 % (14.4 %–43.3 %) and 5.8 % (0.6 %–10.8 %) of cancer burden, respectively.
About 93 % (88.3 %–95.6 %) of oral cavity cancers were explained by all risk factors, 94.3 % (88.4 %–97.2 %) in men
and only 74.1 % (47.0 %–87.3 %) in women.
Conclusion: Our study emphasizes the role of combined tobacco and alcohol consumption in the oral cavity
cancer burden in France and gives an indication of the proportion of cases attributable to other risk factors. Most
of oral cavity cancers are attributable to concurrent smoking and drinking and would be potentially preventable
through smoking or drinking cessation. If the majority of cases are explained by recognized or suspected risk
factors in men, a substantial number of cancers in women are probably due to still unexplored factors that remain
to be clarified by future studies.
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Background
Oral cavity cancer [1] is an important cause of morbidity
and mortality in France, with approximately 6000 new
cases and 1500 deaths each year [2] and incidence rates
among the highest in the world [3]. In France, the inci-
dence of oral cavity cancer has been strongly decreasing
among men and strongly increasing in women [4].
Changes in the prevalence of the main risk factors, i.e. a
decrease of daily smoking in men and an increase in
women, and a decrease in alcohol drinking in both gen-
ders, are likely to partially explain these trends [4]. Des-
pite the high incidence of oral cavity cancer in France,
the role of tobacco smoking and alcohol drinking has
been rarely studied [5–8], while other potential risk fac-
tors (e.g. family history of head and neck cancer (HNC),
body mass index (BMI), personal medical history, tea
consumption) were examined only in the present case–
control study [9–11].
Population attributable risks (PARs) are useful tool to
estimate the burden of risk factors in cancer incidence.
Although several epidemiological studies examined the
joint effect of tobacco and alcohol consumption and found
evidence of an interaction on an additive [12] or multi-
plicative [13–18] scale, only few of them estimated the
proportion of HNC that can be attributable to tobacco
consumption alone, alcohol consumption alone, and their
combined consumption [13, 15, 17]. However, the under-
standing of the independent and joint effects of tobacco
and alcohol could have important implications for preven-
tion. A pooled analysis within the International Head and
Neck Cancer Epidemiology (INHANCE) Consortium [15]
and a European case–control study [13] reported similar
PARs of oral cavity cancer to tobacco and/or alcohol con-
sumption (PAR = 63.7 % and 61.3 %, respectively), but
lower than that reported by one case–control study con-
ducted in Latin America (PAR = 83.7 % for oral cavity and
oropharynx) [16]. PARs of HNC to tobacco and alcohol
differed by gender (greater in men that in women), and by
age (greater in older subjects than in younger subjects) in
three studies [13, 15, 19].
The few available studies on HNC related to alcohol
and tobacco consumption which provided separate PARs
of oral cavity cancer did not include French data, and
none performed analysis on oral cavity cancers stratified
by gender, age or anatomic location. However, concerning
the carcinogenic effect of tobacco smoking and alcohol
drinking, differences between oral subsites have been ob-
served in some epidemiological studies [5, 20–25]. More-
over, among the other potential risk factors of HNC, only
the PAR of HNC to a family history of HNC has been esti-
mated. It was low, in the order of 2 % [26], although
higher (23.2 %) in young adults with family history of
early-onset cancer [19]. Estimates for PARs to other sus-
pected risk factors were never provided.
In a previous analysis [5], we reported PARs for to-
bacco smoking and/or alcohol drinking for oral cavity
subsites, but we did not assess the PAR due to the inter-
action between these factors, nor did we estimate PARs
by gender and age. Also, it would be of interest to exam-
ine PARs of oral cavity cancer for other suspected risk
factors, never provided previously.
Using data from the ICARE study, we conducted the
present analysis to (i) estimate in France the proportion
of oral cavity cancers attributable to the effect of tobacco
smoking alone, alcohol drinking alone and to their joint
effect; (ii) assess the PARs due to several potential risk
factors previously observed in this study population
(family history of HNC, personal history of oral candid-
iasis, low BMI and low tea consumption); (iii) examine
differences in PARs, if any, by subsite, gender and age.
Methods
Study population
The study design, study population and data collection
methods of the ICARE (Investigation of occupational
and environmental CAuses of REspiratory cancers) study
have been described in details elsewhere [27]. Briefly, the
ICARE study is a multi-centre population-based case–
control study on lung and HNC, carried out from 2002
to 2007 in 10 French administrative areas, covered by a
general cancer registry.
The present analysis included only cases with oral cav-
ity cancer (International Classification of Diseases 10th
revision [ICD-10] codes C01-C06 [1]) and all controls.
Cases eligibility criteria included histological confirmed
primary malignant tumours of the oral cavity who were
aged 75 or less at interview. Clinical and anatomopatholo-
gical reports were reviewed to determine the topography
and histological type of the tumours according to the
International Classification of Diseases for Oncology [28].
Among the 1316 cases identified as eligible, 968 cases
could be contacted, of which 792 (81.8 %) agreed to par-
ticipate. Analyses were restricted to squamous cell carcin-
omas (772 cases). Controls were selected from the general
population by random digit dialling, and were frequency-
matched to the cases by age, gender and area of residence.
Of the 4673 eligible controls, 4411 could be contacted,
and 3555 (80.6 %) agreed to participate. All subjects gave
their written informed consent for the participation in the
study. The ICARE study was approved by the Institutional
Review Board of the French National Institute of Health
and Medical Research (IRB-Inserm, n° 01–036), and by
the French Data Protection Authority (CNIL, n° 90120).
Data collection
Subjects were interviewed face-to-face with standardized
questionnaires by trained interviewers. The question-
naire included information about socio-demographic
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characteristics, medical and family history, detailed to-
bacco, alcohol and tea consumption (quantity, duration,
type of product, age at starting, time since cessation),
and anthropometric measurements (height, weight at
interview, two years before and at age 30). Ever smokers
were defined as subjects who had smoked at least 100
cigarettes in their lifetime, or who had smoked at least
one pipe, cigar or cigarillo per week for at least one year.
Ever alcohol and tea drinkers were defined as subjects
who had consumed at least one drink per month for at
least one year. To ascertain the medical history, study
participants were asked if, throughout their lives, they
had ever had one or more diseases among those men-
tioned in a list, including oral candidiasis. To ascertain
the family history of cancer, subjects were asked if their
biological mother and father and their full brothers or
sisters had ever had a cancer. If the answer was “yes”,
the subjects were asked to specify the type of cancer.
A summary version of the questionnaire was used when
the subject was too sick to answer the complete question-
naire (83 cases (10.8 %) and 74 controls (2.1 %)). This
questionnaire did not include information about an-
thropometric measurements, family and medical history,
and tea consumption. Therefore, these subjects were
excluded from the present analysis that finally included
689 cases and 3481 controls.
Statistical analysis
Unconditional logistic regression models were used to
estimate ORs, PARs and their 95 % CIs. The models in-
cluded the variables age (< 45, 45–60 > 60 years), gender,
area of residence (10 administrative areas), education level
(primary or less, vocational secondary, general secondary
and university), alcohol and tobacco consumption (never
use of tobacco and alcohol as reference, tobacco but never
alcohol use (tobacco alone), alcohol but never tobacco use
(alcohol alone) and tobacco and alcohol use (joint effect)),
BMI two years before the interview (< 25 kg.m−2/≥
25 kg.m−2), family history of HNC in first degree relatives
(yes/no), personal history of oral candidiasis (yes/no) and
tea drinking (never/ever). The choice of adjusting for
these variables was justified by our previous results that
showed lower risks of oral cavity cancer in overweight/
obese subjects compared to normal/underweight subjects
[9] and in ever tea drinkers compared to never drinkers
[11], and higher risks in subject with history of oral can-
didiasis or family history of HNC compared with subjects
without history [10].
Logistic regression models were also used to deter-
mine the multiplicative interaction parameter Ψ and the
95 % CI by including the dummy variables ever tobacco
consumption, ever alcohol consumption and their prod-
uct term. An interaction parameter Ψ greater than 1
indicated an interaction between tobacco and alcohol
consumption greater than one a multiplicative scale.
PARs and their 95 % CIs were calculated using the
‘aflogit’ procedure in STATA [29], which estimates the
adjusted measures of population attributable fraction
from a logistic regression model adapted to case–control
studies, on the basis of the method of Greenland and
Drescher [30].
Stratified analyses were conducted by gender and age
(< 45, 45–60, > 60 years). Polytomous regression modes
were used to estimate ORs, PARs and 95 % CI by sub-
site (base of the tongue, mobile tongue, gums, floor of
the mouth, hard/soft palate, and other parts of the oral
cavity).
All statistical tests were two-sided. Analyses were per-
formed using the Stata Statistical Software release 10.0
(StataCorp 2007, College Station, Texas, USA).
Results
Men represented more than two thirds of both cases and
controls (78.2 % and 80.6 %, respectively). Cases were
younger and had lower education level than controls
(mean of age 56.8 and 58.5, respectively; university degree
12.3 % and 25.9 %, respectively). The most frequent
tumour location was the floor of the mouth (27.7 %),
followed by the mobile tongue (23.2 %), the base of the
tongue (18.8 %), other parts of the mouth (11.5 %) and
soft palate (10.8 %). Gums and hard palate represented
only 5.7 % and respectively 2.3 % of cancer locations.
PAR to tobacco and alcohol consumption (Table 1)
ORs, 95 % CIs and PARs of oral cavity cancer to alcohol
drinking alone, tobacco smoking alone and their joint
consumption, and the multiplicative interaction parameter
are presented in Table 1. Alcohol drinking alone was not
associated with the risk of oral cavity cancer, while exclu-
sive tobacco smoking and joint consumption of alcohol
and tobacco increased the risk. The joint effect was
greater than multiplicative (interaction parameter Ψ > 1).
PARs were 0.3 % (95 % CI −3.9-3.9) for alcohol consump-
tion alone, 12.7 % (6.9–18.0) for tobacco consumption
alone, 69.9 % (64.4–74.7) for their joint consumption, and
82.9 % (73.8–88.5) for total consumption (alcohol and/or
tobacco).
Differences between subsites were observed: the greatest
PARs to tobacco consumption alone, joint and total con-
sumption of alcohol and tobacco were observed for floor
of the mouth cancer (15.5 % (6.7–23.6) for tobacco con-
sumption alone, 79.6 % (70.8–85.7) for alcohol and to-
bacco consumption, and 95.6 % (82.3–98.9) for alcohol
and/or tobacco consumption). The lowest PARs to to-
bacco consumption alone, joint and total consumption of
alcohol and tobacco were found for gum cancer (11.1 %
(−30.1–39.2) for tobacco consumption alone, 26.2 %
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Table 1 Odds ratios (OR), population attributable risks (PAR) and confidence intervals (95 % CI) for oral cavity cancer associated with
tobacco smoking, alcohol drinking and their joint effect, overall and by subsite, gender and age. ICARE study
Cases Controls OR (95 % CI)a PAR (95 % CI)a
(N = 689) (N = 3481)
Oral cavity overall
None consumption 37 926 reference
Alcohol alone 14 297 1.1 (0.4–2.6) 0.3 % (−3.9–3.9)
Tobacco alone 135 1189 3.2 (1.9–5.3) 12.7 % (6.9–18.0)
Tobacco and alcohol 486 1040 17.3 (10.6–28.3) 69.9 % (64.4–74.7)
Total (Alcohol and/or tobacco) Ψ = 5.2 (1.9–13.8) 82.9 % (73.8–88.5)
By subsite
Base of tongue
None consumption 5 926 reference
Alcohol alone 5 297 0.8 (0.1–7.3) -**
Tobacco alone 28 1189 3.3 (1.1–9.6) 14.5 % (0.6–26.5)
Tobacco and alcohol 90 1040 13.1 (4.6–37.3) 65.4 % (49.1–76.5)
Total (Alcohol and/or tobacco) Ψ = 4.8 (0.5–46.1) 79.6 % (50.6–91.6)
Mobile tongue
None consumption 16 926 reference
Alcohol alone 3 297 0.6 (0.1–4.7) -**
Tobacco alone 40 1189 3.1 (1.3–7.3) 16.5 % (3.5–27.7)
Tobacco and alcohol 100 1040 12.0 (5.1–28.5) 60.1 % (46.1–70.5)
Total (Alcohol and/or tobacco) Ψ = 6.9 (0.8–60.5) 75.7 % (51.3–87.9)
Gum
None consumption 5 926 reference
Alcohol alone 2 297 0.8 (0.1–8.0) -**
Tobacco alone 12 1189 1.5 (0.4–5.4) 11.1 % (−30.1–39.2)
Tobacco and alcohol 18 1040 2.6 (0.7–9.6) 26.2 % (−13.9–52.2)
Total (Alcohol and/or tobacco) Ψ = 2.0 (0.2–23.4) 36.4 % (−62.3–75.0)
Floor of the mouth
None consumption 2 926 reference
Alcohol alone 2 297 2.4 (0.2–27.7) 0.5 % (−5.8–6.4)
Tobacco alone 33 1189 11.1 (2.5–48.7) 15.5 % (6.7–23.6)
Tobacco and alcohol 146 1040 88.1 (20.3–381.8) 79.6 % (70.8–85.7)
Total (Alcohol and/or tobacco) Ψ = 3.3 (0.3–38.3) 95.6 % (82.3–98.9)
Soft palate
None consumption 4 926 reference
Alcohol alone 0 297 not estimated
Tobacco alone 11 1189 2.0 (0.5–8.2) 7.2 % (−9.4–21.3)
Tobacco and alcohol 57 1040 17.5 (4.7–65.3) 75.1 % (55.1–86.1)
Total (Alcohol and/or tobacco) Ψ not estimated 82.3 % (44.9–94.3)
Other parts of the mouth
None consumption 5 926 reference
Alcohol alone 2 297 4.4 (0.6–34.1) 3.4 % (−6.6–12.5)
Tobacco alone 10 1189 2.2 (0.4–12.8) 4.9 % (−8.5–16.6)
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(−13.9–52.2) for joint consumption of alcohol and to-
bacco, and 36.4 % (−62.3–75.0) for alcohol and/or to-
bacco consumption). For the base of the tongue and
soft palate, oral subsites generally grouped with the
oropharynx, the PARs were similar to that observed
for mobile tongue and other parts of the mouth; for
example, the total PAR was 79.6 % (50.6–91.6) for base
of the tongue, 75.7 % (51.3–87.9) for mobile tongue,
82.3 % (44.9–94.3) for soft palate and 87.6 % (50.1–
96.9) for other parts of the mouth. With respect to the
exclusive alcohol drinking, the PARs were low and
some negative values were found when the ORs were
below 1 for base of the tongue, mobile tongue and
gum cancers.
Table 1 Odds ratios (OR), population attributable risks (PAR) and confidence intervals (95 % CI) for oral cavity cancer associated with
tobacco smoking, alcohol drinking and their joint effect, overall and by subsite, gender and age. ICARE study (Continued)
Tobacco and alcohol 61 1040 27.7 (5.7–135.1) 79.3 % (59.9–89.2)
Total (Alcohol and/or tobacco) Ψ = 2.8 (0.3–26.5) 87.6 % (50.1–96.9)
By gender
Male
None consumption 11 482 reference
Alcohol alone 9 247 0.7 (0.2–2.3) –**
Tobacco alone 94 967 2.7 (1.3–5.4) 9.8 % (3.0–16.1)
Tobacco and alcohol 431 1008 13.2 (6.8–25.5) 74.0 % (66.5–79.9)
Total (Alcohol and/or tobacco) Ψ = 7.2 (2.1–24.8) 83.3 % (68.8–91.1)
Female
None consumption 26 444 reference
Alcohol alone 5 50 1.4 (0.3–7.1) 0.9 % (−10.6–11.1)
Tobacco alone 41 222 3.6 (1.7–7.8) 22.4 % (6.8–35.5)
Tobacco and alcohol 55 32 41.9 (17.8–98.7) 45.4 % (32.7–55.6)
Total (Alcohol and/or tobacco) Ψ = 8.0 (1.4–46.5) 68.7 % (49.4–80.6)
By age
< 45 years
None consumption 5 124 reference
Alcohol alone 0 24 not estimated
Tobacco alone 10 207 1.6 (0.3–8.8) 8.0 % (−29.8–34.8)
Tobacco and alcohol 33 62 31.5 (4.4–123.1) 67.7 % (41.5–82.1)
Total (Alcohol and/or tobacco) Ψ not estimated 75.7 % (20.6–93.9)
45–60 years
None consumption 15 300 reference
Alcohol alone 3 97 0.4 (0.1–3.3) -**
Tobacco alone 66 513 2.9 (1.4–6.0) 10.9 % (3.5–17.8)
Tobacco and alcohol 297 399 22.1 (10.9–44.7) 75.2 % (68.3–80.5)
Total (Alcohol and/or tobacco) Ψ = 18.4 (2.2–152.3) 85.5 % (73.4–92.1)
> 60 years
None consumption 17 502 reference
Alcohol alone 11 176 2.4 (0.8–6.8) 2.5 % (−3.8–8.4)
Tobacco alone 59 469 5.1 (2.3–11.0) 16.8 % (7.9–24.7)
Tobacco and alcohol 156 579 16.4 (7.7–35.1) 62.8 % (52.7–70.8)
Total (Alcohol and/or tobacco) Ψ = 1.4 (0.4–4.3) 82.1 % (67.4–90.2)
**Negative population attributable risk (PAR) (OR < 1 and not significant)
ORs and PARs for hard palate were not estimated because of lack of cases in the reference category (0 never drinker never smoker)
aLogistic model adjusted for age, gender, area of residence, education level, tobacco and alcohol consumption, BMI two years before the interview, family history
of head and neck cancer, history of candidiasis and tea consumption
Ψ = alcohol – tobacco interaction term
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The PARs were lower in women than in men for both
the joint and total consumption of alcohol and tobacco
(in women: 45.4 %, 32.7–55.6, and 68.7 %, 49.4–80.6, re-
spectively; in men: 74.0 %, 66.5–79.9, and 83.3 %, 68.8–
91.1, respectively). Concerning the PARs stratified by age,
it was difficult to conclude to any difference between sub-
jects younger than 45 compared to subjects aged 45–60 or
older because CIs are large and overlapped.
PAR to other risk factors
ORs, PARs and 95 % CI for oral cavity cancer associated
with other risk factors than alcohol and tobacco are pre-
sented in Table 2. Around 35 % (25.7–43.6) of oral cavity
cancer cases were attributable to a BMI < 25.0 kg.m−2.
Since the confidence intervals overlapped, it is not
possible to conclude to significant differences between
subsites. Among men, the corresponding PAR was 39.9 %
(30.0–48.3). No association was observed in women be-
tween BMI and oral cavity cancer (OR = 1.1 (0.6–2.0)),
leading to a small PAR (4.2 %, −38.4–33.7). No significant
differences were observed in PAR stratified by age.
Only few oral cavity cancers were attributable to having
a family history of HNC in first degree relatives (5.8 %,
0.6–10.8). No noticeable differences were observed in
PAR by subsite or by age. The PARs were 6.8 % in men
and 2.1 % in women with overlapping CIs.
Very few oral cancer cases were attributable to a per-
sonal history of oral candidiasis (1.9 %, −2.1–5.7 %). We
did not find any significant difference in PARs stratified
by subsite, gender or age.
The PAR associated with never drinking tea was 30.3 %
(14.4–43.3). The highest ORs and PARs were observed for
soft palate and other parts of the mouth but confidence
intervals were large and overlapped and it was difficult to
conclude to any difference. The PAR was 38.0 % in men
and only 13.9 % in women, confidence intervals overlap-
ping. Analysis stratified by age did not show significant
differences in PAR.
PAR to all risk factors combined
The PAR to all factors combined was around 93 %
(95 % CI 88.3–95.6) with the lowest value of 78.5 % (95 %
CI 15.2–94.6) for the gum cancer and the highest value of
98.0 % (95 % CI 91.4–99.5) for the floor of the mouth
cancer (Table 3). The PARs varied by gender, the studied
risk factors explaining 94.3 % (95 % CI 88.4–97.2) of cases
in men, and only 74.1 % (95 % CI 47.0–87.3) of them in
women, mainly because of differences between the two
genders in risks related to tobacco and alcohol consump-
tion. No significant difference in PAR by age was found.
Discussion
The ICARE study is one of the few studies investigating
the PARs of oral cavity cancer to several recognized or
suspected risk factors. The PARs should in principle be
estimated for risk factors with a proven causal relation-
ship with a cancer/the disease. Nevertheless, we also cal-
culated PARs for several suspected risk factors. Some of
these factors (family and medical history) are not modifi-
able or can hardly be subject to preventive measures. In
addition, obviously, it is not possible to recommend a
weight gain that was inversely associated with the risk
oral cavity cancer, because of the negative consequences
on many other diseases. However, the objective here was to
assess the impact of each risk factor, prioritize them, and
determine the proportion of oral cavity cancers that re-
mains to be possibly explained by other unexplored factors.
Our results have shown that the proportion of risk
attributable to tobacco smoking alone was greater than
that attributable to alcohol drinking alone. Smoking was
an independent risk factor for oral cavity cancer while
drinking, in the absence of smoking, conferred little and
no significant risk. These results are similar to those re-
ported in other studies [12, 13, 15, 17, 18, 31, 32]. Con-
sistently with the difference in risks associated with
smoking or smoking and drinking by subsite found in
our study [5] as elsewhere [20–25], we observed differ-
ences in the estimates of PARs across oral cavity sub-
sites. Some negative estimates for the PAR to exclusive
alcohol drinking were observed. This does not indicate a
protective effect of alcohol since the corresponding ORs
did not suggest statistically significant inverse associa-
tions. We also observed a greater than multiplicative
interaction between tobacco and alcohol, consistent with
previous studies [13–18].
The proportion of cases attributable to the joint effect
of tobacco and alcohol was around 70 %, confirming that
tobacco and alcohol together explain the majority of oral
cavity cancer burden in France. This result is consistent
with that reported by one case–control study conducted
in Latin America [17], but higher than that observed in
an international pooled analysis [15] and a European
case–control study [13].
Differences in PARs by gender were observed, particu-
larly with regards to the attributable risks to tobacco and
alcohol. The PAR to their joint consumption was higher
in men than in women (74.0 % and 45.4 %, respectively),
consistent with previous studies [13, 15, 17]. This can be
explained by the higher proportion of drinkers and/or
smokers in men than in women; the prevalence of com-
bined consumption was around 78 % in male cases and
only 41 % in female cases. Nevertheless, we cannot rule
out more underreporting of these expositions among
women than among men, especially for alcohol drinking,
which is less socially accepted among women.
Conversely to the available studies [13, 15, 19], we did
not find a lower proportion of oral cavity cancers attrib-
utable to alcohol and tobacco consumption in subjects
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Table 2 Odds ratios (OR), population attributable risks (PAR) and confidence intervals (95 % CI) for oral cavity cancer associated with
body mass index, family history of head and neck cancer, history of oral candidiasis, and tea consumption, overall and by subsite,
gender and age. ICARE study
Cases Controls OR (95 % CI)a PAR (95 % CI)a
N = 689 N = 3481
E+/E- E+/E-
Body mass index 2 years before the interview <25 kg.m−2 vs. ≥25 kg.m−2
Oral cavity overall 408/253 1405/1944 2.4 (1.8–3.0) 35.3 % (25.7–43.6)
By subsite Base of tongue 67/56 1405/1944 2.9 (1.8–5.0) 42.4 % (20.5–58.2)
Mobile tongue 91/64 1405/1944 1.9 (1.2–2.9) 25.8 % (5.1–42.1)
Gums 23/13 1405/1944 4.2 (1.5–12.2) 55.1 % (4.7–78.9)
Floor of mouth 110/71 1405/1944 2.4 (1.6–3.6) 35.3 % (17.9–49.1)
Soft palate 49/22 1405/1944 2.6 (1.4–4.8) 37.6 % (9.6–56.9)
Other parts of the mouth 56/22 1405/1944 2.7 (1.4–5.1) 39.1 % (10.1–58.8)
By gender Male 332/203 1022/1600 2.8 (2.1–3.6) 39.9 % (30.0–48.3)
Female 76/50 383/344 1.1 (0.6–2.0) 4.2 % (−38.4–33.7)
By age <45 33/12 222/177 3.1 (1.0–9.1) 47.3 % (2.1–72.8)
45–60 272/144 601/797 2.6 (1.8–3.6) 40.4 % (27.3–51.2)
>60 103/97 582/970 2.1 (1.4–3.1) 26.7 % (11.3–39.5)
Family history of head and neck cancer (yes vs. no)
Oral cavity overall 68/462 157/2784 1.9 (1.3–2.8) 5.8 % (0.6–10.8)
By subsite Base of tongue 17/73 157/2784 2.6 (1.3–5.3) 11.2 % (−0.9–21.9)
Mobile tongue 17/106 157/2784 2.5 (1.3–4.8) 8.6 % (−0.9–17.3)
Gums 1/24 157/2784 0.9 (0.1–7.5) - **
Floor of mouth 13/138 157/2784 1.6 (0.8–3.3) 3.4 % (−5.0–11.1)
Soft palate 9/50 157/2784 2.4 (0.9–6.1) 7.0 % (−6.1–18.6)
Other parts of the mouth 5/58 157/2784 1.1 (0.3–3.3) 0.6 % (−12.5–12.2)
By gender Male 54/375 120/2184 2.1 (1.4–3.3) 6.8 % (1.0–12.2)
Female 10/87 37/600 1.3 (0.4–3.9) 2.1 % (−12.9–15.1)
By age <45 3/35 16/353 4.9 (0.9–27.2) 8.5 % (−14.1–26.7)
45–60 41/293 67/1189 2.0 (1.1–3.6) 6.7 % (−0.4–13.3)
>60 20/134 74/1242 1.6 (0.8–3.0) 4.0 % (−4.1–11.5)
Personal history of oral candidiasis (yes vs. no)
Oral cavity overall 14/645 80/3224 4.2 (1.7–10.5) 1.9 % (−2.1–5.7)
By subsite Base of tongue 3/120 80/3224 1.7 (0.2–17.3) 0.6 % (−7.1–7.7)
Mobile tongue 5/145 80/3224 9.2 (2.9–29.1) 4.9 % (−1.8–11.3)
Gums 0/36 80/3224 not estimated
Floor of mouth 3/180 80/3224 3.9 (0.8–20.2) 1.2 % (−5.2–7.3)
Soft palate 1/71 80/3224 3.3 (0.3–35.9) 1.4 % (−7.8–9.9)
Other parts of the mouth 1/77 80/3224 3.6 (0.4–32.9) 1.6 % (−7.3–9.7)
By gender Male 10/526 41/2548 2.9 (0.8–10.1) 1.2 % (−3.2–5.3)
Female 4/119 39/676 5.2 (1.1–24.8) 4.6 % (−6.9–14.8)
By age <45 0/41 21/389 not estimated
45–60 10/403 27/1341 9.8 (2.7–35.9) 2.9 % (−2.2–7.8)
>60 4/201 32/1494 1.6 (0.3–8.6) 0.6 % (−5.1–5.9)
Radoï et al. BMC Cancer  (2015) 15:827 Page 7 of 10
younger than 45, probably because of the small size of
this category compared to the older age groups.
In our study, PAR of oral cavity cancer to family history
of HNC was around 6 %, greater than that reported for
HNC overall in the pooled analysis within INHANCE
Consortium (around 2 %) [26]. This difference may be ex-
plained by the higher percentage of subjects exposed to a
family history of HNC in our study (9.9 % in cases and
4.5 % in controls) than in the pooled analysis (3.6 % in
cases and 1.8 % in controls).
Low versus high BMI and never versus ever consump-
tion of tea appear to be responsible for a significant num-
ber of oral cavity cancers, especially in men. The possible
role of body fat in the distribution of the lipophilic carcin-
ogens derived from tobacco smoke [33] and the implica-
tion of tea polyphenols in the apoptosis and the inhibition
of the growth of oral carcinoma cells [34, 35] might
explain these findings.
Approximately 93 % of cases of oral cavity cancer
overall, 94 % in men and only 74 % in women, are ex-
plained by all the studied factors. This leaves about 7 %
of cases to be explained by other risk factors that we
have not been able to take into account, of which 6 % in
men and 26 % in women. This result emphasizes the
role of other risk factors in women, such as human pap-
illomavirus (HPV) infection, diet, hormonal factors or
specific genetic factors of cancer susceptibility.
Strengths of our study are the multicenter design and
the study size that allowed us to perform stratified ana-
lyses by anatomic subsite, gender and age.
Some limitations of our study exist. The subjects self-
reported their own consumption of tobacco, alcohol and
tea, anthropometric measurements, medical and family
history. Thereby, recall bias could not be ruled out and
it is possible that the cases had a higher motivation than
the controls to recall tobacco and alcohol consumption
as well as medical and family history, known as potential
risk factors of cancer. Nevertheless, we do not think that
underreporting of alcohol consumption may explain its
negligible impact because alcohol drinking is socially ac-
cepted in France. In France, only 8.4 % of people reported
never having drunk alcohol [36], a proportion close to that
Table 2 Odds ratios (OR), population attributable risks (PAR) and confidence intervals (95 % CI) for oral cavity cancer associated with
body mass index, family history of head and neck cancer, history of oral candidiasis, and tea consumption, overall and by subsite,
gender and age. ICARE study (Continued)
Tea consumption (never vs. ever)
Oral cavity overall 443/150 2025/1334 1.7 (1.3–2.2) 30.3 % (14.4–43.3)
By subsite Base of tongue 80/37 2025/1334 1.0 (0.6–1.7) 0.1 % (−44.6–30.9)
Mobile tongue 102/36 2025/1334 1.5 (0.9–2.5) 23.2 % (−13.2–47.9)
Gums 20/10 2025/1334 1.9 (0.6–6.0) 36.1 % (−57.3–74.0)
Floor of mouth 128/38 2025/1334 1.5 (0.9–2.3) 23.6 % (−7.1–45.4)
Soft palate 48/13 2025/1334 4.3 (1.7–10.7) 67.5 % (29.3–85.0)
Other parts of the mouth 55/13 2025/1334 4.2 (1.6–11.1) 67.6 % (24.1–86.2)
By gender Male 377/99 1692/928 1.9 (1.4–2.6) 38.0 % (21.3–51.2)
Female 66/51 333/406 1.3 (0.7–2.4) 13.9 % (−18.1–37.3)
By age <45 231/172 28/14 2.3 (0.7–7.8) 45.7 % (−37.1–78.5)
45–60 848/561 284/93 1.4 (0.9–2.1) 22.2 % (−3.22–41.2)
>60 946/601 131/43 1.9 (1.3–3.1) 38.2 % (13.0–56.1)
**Negative population attributable risk (OR < 1 and not significant)
aLogistic model adjusted for age, gender, area of residence, education level, tobacco and alcohol consumption, BMI 2 years before the interview, family history of
head and neck cancer, history of candidiasis and tea consumption
E+ exposed subject/E- non-exposed subject to a risk factor
Table 3 Population attributable risks (PAR) and their confidence
intervals (95 % CI) for oral cavity cancer associated with all risk
factors, overall, by subsite, gender and age. ICARE study
PAR (95 % CI)a
Oral cavity overall 92.8 % (88.3–95.6)
By subsite Base of tongue 89.9 % (71.6–96.4)
Mobile tongue 88.1 % (72.4–94.9)
Gums 78.5 % (15.2–94.6)
Floor of mouth 98.0 % (91.4–99.5)
Soft palate 96.8 % (86.3–99.3)
Other parts of the mouth 97.5 % (86.9–99.5)
By gender Male 94.3 % (88.4–97.2)
Female 74.1 % (47.0–87.3)
By age <45 94.3 % (59.4–99.2)
45–60 93.7 % (87.3–96.9)
>60 92.4 % (84.2–96.4)
aLogistic model adjusted for age, gender, area of residence, education level,
tobacco and alcohol consumption, BMI 2 years before the interview, family
history of head and neck cancer, history of candidiasis and tea consumption
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of never drinkers among our controls (8.6 %). We think
that recall bias for BMI and tea drinking would be non-
differential among cases and controls, since these factors
are not generally known to be related to oral cavity cancer.
If present, this bias would tend to attenuate the associa-
tions with cancer risk. In addition, many studies have
shown that subjects in case–control studies are able to
accurately self-report family history of common types of
cancer among first-degree relatives [37, 38] and tea con-
sumption [39].
Information about other suspected or known risk fac-
tors for oral cavity cancer such as HPV infection or diet
was not collected in our study and residual confounding
cannot be excluded. HPV infection is a recognized risk
factor for base of the tongue and tonsils cancers, but less
for the other HNC [40]. However, adjustment for HPV
seemed to have only minor effects on the estimated ORs
for alcohol and tobacco [41–43]. In addition, an Inter-
national Agency for Cancer Research report on attribut-
able causes of cancer in France estimated the PAR of
oral cavity and oropharynx cancers to HPV infection
low and similar in both genders (6.7 %) [44]. A diet rich
in fruits and vegetables, generally associated with lower
body size, have a protective effect against HNC [45–47].
Thus, confounding by diet is unlikely to explain the in-
verse association between BMI and oral cavity cancer
that we found, although it could reduce the precision of
the ORs. Also, we think that the lack of information on
HPV and diet could not explain the differences in PARs
that we observed.
Conclusion
While we did not observe an independent effect of alcohol
on oral cavity cancer risk in our study, concurrent smok-
ing and drinking are responsible for the majority of oral
cavity cancers, especially among men. In terms of public
health, this study suggests that a reduction of combined
tobacco and alcohol consumption could result in a signifi-
cant decrease of oral cancer. Ninety-three percent of cases
overall and 94 % in men are explained by known or sus-
pected risk factors. However, a substantial proportion of
oral cavity cancer among women (26 %) cannot be attrib-
uted to either established or suspected risk factors. Still
unexplored factors conferring oral cancer risk among
women remain to be clarified by future studies.
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